Drug-induced prolongation of the QT interval: why the regulatory concern?

被引：0
|
作者：
Shah, R. [1 ]
机构：
[1] Med Control Agcy, London, England
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2001年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [41] Impact of different contraceptive pills on the potentiation of drug-induced QT interval prolongation
    Salem, J. E.
    Dureau, P.
    Hulot, J. S.
    Funck-Brentano, C.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 20 - 20
  • [42] Problems of heart rate correction in assessment of drug-induced QT interval prolongation
    Malik, M
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (04) : 411 - 420
  • [43] Mechanisms of Drug Induced QT Interval Prolongation
    Luis Ponte, Marcelo
    Alberto Keller, Guillermo
    Di Girolamo, Guillermo
    [J]. CURRENT DRUG SAFETY, 2010, 5 (01) : 44 - 53
  • [44] QT PRODACT: In vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation
    Ando, K
    Hombo, T
    Kanno, A
    Ikeda, H
    Imaizumi, M
    Shimizu, N
    Sakamoto, K
    Kitani, S
    Yamamoto, Y
    Hizume, S
    Nakai, K
    Kitayama, T
    Yamamoto, K
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 99 (05) : 487 - 500
  • [45] Risk assessment of drug-induced QT prolongation
    Isbister, Geoffrey K.
    [J]. AUSTRALIAN PRESCRIBER, 2015, 38 (01) : 20 - 24
  • [46] QT PRODACT: Sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation
    Miyazaki, H
    Watanabe, H
    Kitayama, T
    Nishida, M
    Nishi, Y
    Sekiya, K
    Suganami, H
    Yamamoto, K
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 99 (05) : 523 - 529
  • [47] Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities
    Eleonora Marostica
    Karel Van Ammel
    Ard Teisman
    Koen Boussery
    Jan Van Bocxlaer
    Filip De Ridder
    David Gallacher
    An Vermeulen
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2015, 42 : 659 - 679
  • [48] Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction
    Huang, Chien-Yu
    Overholser, Brian R.
    Sowinski, Kevin M.
    Jaynes, Heather A.
    Kovacs, Richard J.
    Tisdale, James E.
    [J]. PLOS ONE, 2024, 19 (08):
  • [49] Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine
    Letsas, Konstantinos P.
    Sideris, Antonios
    Kounas, Stavros P.
    Efremidis, Michalis
    Korantzopoulos, Panagiotis
    Kardaras, Fotios
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 109 (02) : 273 - 274
  • [50] Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective
    Pollard, C. E.
    Valentin, J-P
    Hammond, T. G.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (07) : 1538 - 1543
12345